MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
An Interview With Peter J. Pappas, MD
The outgoing president of the American Venous Forum discusses its goals, as well as the areas of venous disease treatment that need the most attention.
Upcoming IVC Filter Data From the American Venous Registry
The importance of data collection and how you can participate in much-needed research.
By The American Venous Forum
American Venous Registry Launches IVC Filter Module
June 16, 2011—The American Venous Forum (AVF) announced the launch of the Inferior Vena Cava (IVC) Filter Module for its American Venous Registry (AVR).
American Venous Forum to Launch American Venous Registry
November 15, 2010—The American Venous Forum (AVF) announced that it will launch the American Venous Registry (AVR) at its 23rd annual meeting to be held in San Diego, California, on February 23 through 26, 2011.
Varicose Vein Registry Launched for the Vascular Quality Initiative
January 26, 2015—The American Venous Forum (AVF) and the Society for Vascular Surgery Patient Safety Organization (SVS PSO) announced the launch of the Varicose Vein Registry (VVR) for the Vascular Quality Initiative (VQI).
Education in Venous Disease
Explore the ways interventionists can pursue further expertise by expanding their knowledge and techniques.
By Steve Elias, MD, FACS, FACPH
American Venous Forum Petitions CMS on Proposed 2021 Reimbursement Changes
October 7, 2020—The American Venous Forum (AVF) announced that the AVF Health Policy Committee has submitted comment letters to the United States Centers for Medicare and Medicaid Services (CMS) to address several significant regulatory issues.
SVS, AVF Announce Agreement Toward Future Collaborative Efforts
February 14, 2018—The Society for Vascular Surgery (SVS) and the American Venous Forum (AVF) jointly announced an agreement laying the groundwork for future collaboration.
Guidelines for Early Thrombus Removal in Acute DVT Published
April 20, 2012—The Society for Vascular Surgery and the American Venous Forum have issued clinical practice guidelines for early thrombus removal strategies in acute deep venous thrombosis (DVT).
SVS Vascular Quality Initiative Expands to Include Venous Disease Treatment
January 11, 2013—The Society for Vascular Surgery (SVS) and the American Venous Forum (AVF) announced the expansion of the SVS Vascular Quality Initiative (VQI) to include the treatment of venous disease.
CPT Coding Guidance for VVT Medical’s ScleroSafe Procedure Reviewed by AVF
September 3, 2024—VVT Medical announced that the American Venous Forum (AVF) has provided an official opinion letter regarding CPT coding guidance for the ScleroSafe percutaneous endovenous ablation procedure.
Inari Partners with AVF and NBCA on DEFIANCE RCT Enrollment
October 15, 2024—Inari Medical, Inc. announced a partnership with the American Venous Forum (AVF) and the National Blood Clot Alliance (NBCA) on the DEFIANCE randomized controlled trial (RCT).
MEDCAC Panel to Hear Presentations on Lower Extremity Chronic Venous Disease
June 29, 2016—The Society for Vascular Surgery (SVS) and the American Venous Forum (AVF) recently announced that they have been invited to present information to a panel that will address questions from the Centers for Medicare & Medicaid Services (CMS) on lower extremity chronic venous disease.
Rethink Varicose Veins Campaign Launched to Raise Awareness of Venous Disease
April 18, 2012—The Rethink Varicose Veins educational campaign was recently launched by the American Venous Forum, the Society for Vascular Surgery, the American College of Phlebology, and corporate sponsor Covidien (Mansfield, MA).
Consensus Statement on Nonthrombotic Iliac Vein Lesion Management Published
By Kush R. Desai, MD, FSIR; Kathleen Gibson, MD; Raghu Kolluri, MD, MS, RVT, MSVM; and Saher Sabri, MD, FSIR
SVS and AVF Respond to Findings of MEDCAC Panel on Lower Extremity Chronic Venous Disease
August 15, 2016—The Society for Vascular Surgery (SVS) and the American Venous Forum (AVF) announced that vascular surgeons and vein specialists representing the two organizations presented their support for newer lower extremity chronic venous disease (LECVD) treatments at the July 20 Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) panel hearing on treatment strategies for patients with LECVD.
AVF Issues White Paper on Considerations in Prophylaxis and Treatment of VTE in COVID-19 Patients
April 17, 2020—The COVID-19 subcommittee of the American Venous Forum (AVF) has produced a white paper on the considerations in prophylaxis and treatment of venous thromboembolism (VTE) in COVID-19 patients.
Key Developments in Superficial Venous Disease Management
A rundown of five significant advancements seen in the past year for the treatment and management of superficial venous disease.
By Raghu Kolluri, MD, RVT, RPVI, and Brian Fowler, BS, RVT
BTG Announces 1-Year Data From VANISH-2
February 21, 2014—BTG International Inc. (West Conshohocken, PA) announced that 1-year data on its Varithena polidocanol injectable foam were presented by Kenneth Todd, MD, at the 26th Annual Meeting of the American Venous Forum in New Orleans, LA.
